Clinical Research Directory
Browse clinical research sites, groups, and studies.
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Sponsor: Stephanie B. Seminara, MD
Summary
The goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in women with hypothalamic amenorrhea (HA). The investigators are also examining whether kisspeptin can help women release eggs from their ovaries. Kisspeptin will be administered subcutaneously (SC) for two weeks in a pulsatile fashion. Ultrasound monitoring of ovarian follicular growth and frequent blood sampling (every 10 minutes for up to two hours) will be performed to assess the physiologic response to kisspeptin over time.
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-12-09
Completion Date
2030-05
Last Updated
2025-12-31
Healthy Volunteers
No
Interventions
kisspeptin 112-121
SC administration of kisspeptin for two weeks (pulsatile, approximately every 90 minutes)
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States